Kumar Amresh 4
4 · Acasti Pharma Inc. · Filed May 8, 2024
Insider Transaction Report
Form 4
Kumar Amresh
VP Program Management
Transactions
- Award
Stock Options (Right to Buy)
2024-05-06+19,740→ 19,740 totalExercise: $2.96Exp: 2034-05-06→ Class A Common Shares (19,740 underlying)
Footnotes (1)
- [F1]Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period.